Funded Grants

Repetitive transcranial magnetic stimulation (rTMS) is an effective treatment for patients with depression who have not responded to antidepressant medications.

One percent of Alzheimer’s disease is the early-onset type that runs in families.

Dr David Stojdl’s lab has custom‑built an oncolytic virus biotherapy specifically for the treatment of the devastating brain cancer, glioblastoma multiforme (GBM).

In childhood, medulloblastoma (a form of brain cancer) and neuroblastoma (a cancer that starts in the nerve cells) can be aggressive and hard to treat.

The purpose of this project is to develop promoters. Promoters are pieces of DNA, which act as switches to turn genes on and off.

500,000 Canadians have dementia, a number that will double within a generation due to the ongoing aging demographics of the population, with annual costs estimated to increase from $15B currently to over $150B by the year 2050.

Ms. Nancy Butcher, is a doctoral candidate who is conducting research using advanced brain imaging techniques to measure levels of the brain chemical dopamine, to differentiate between Parkinson’s disease and other motor neuron defects.

The CIFAR Learning in Machines & Brains program brings together 41 researchers to examine what consciousness is and how it comes about.

The CIFAR Humans & the Microbiome program brings together 21 researchers to examine what consciousness is and how it comes about.

The Azrieli Program in Brain, Mind & Consciousness brings together 22 researchers to examine what consciousness is and how it comes about.